Corteva, Inc. is a global agriculture company specializing in the development and sale of seeds and crop protection products. The company operates primarily in two segments: Seed and Crop Protection, offering a range of products that support agricultural productivity and sustainability. Corteva's Seed segment includes corn, soybean, and other oilseeds, while the Crop Protection segment provides herbicides, insecticides, and fungicides to safeguard crops from various threats . The company is committed to innovation, having launched over 400 new products in 2023, including new seed hybrids and crop protection solutions .
-
Seed - Develops and sells a variety of seeds, including corn, soybean, and other oilseeds, with corn being the largest contributor to this segment.
- Corn - Offers a range of corn seed products designed to enhance yield and resilience.
- Soybean - Provides soybean seeds that are engineered for improved performance and disease resistance.
- Other Oilseeds - Includes seeds for various oilseed crops, supporting diverse agricultural needs.
-
Crop Protection - Offers a comprehensive range of products designed to protect crops from weeds, insects, and diseases.
- Herbicides - Supplies herbicides that effectively manage weed growth and enhance crop health.
- Insecticides - Provides insecticides aimed at controlling pest populations and minimizing crop damage.
- Fungicides - Delivers fungicides that prevent and control fungal diseases, ensuring crop quality and yield.
You might also like
| Name | Position | External Roles | Short Bio | |
|---|---|---|---|---|
Charles V. Magro ExecutiveBoard | Chief Executive Officer (CEO) | Board Member at Ingredion Inc., CropLife International, Business Roundtable, IMAGINE Food Collective, University of Waterloo Dean's Advisory Council | CEO of Corteva since November 2021, previously CEO of Nutrien Ltd., with extensive experience in agriculture and chemicals. | View Report → |
David Johnson Executive | Executive Vice President and CFO | None | CFO since September 2024, previously CFO at Atkore Inc. and held finance leadership roles at Eaton Corporation. | |
Judd O’Connor Executive | Executive Vice President, Seed Business Unit | None | EVP of Seed Business Unit since December 2024, previously President of North America Business and Seed Commercial President for North America. | |
Robert D. King Executive | Executive Vice President, Crop Protection Business Unit | None | EVP of Crop Protection since April 2022, previously held leadership roles at Nouryon, PPG, and Nutrien Ltd.. | |
David C. Everitt Board | Director | Director at Enviri Corporation, Allison Transmission Holdings, Brunswick Corporation | Director since March 2021, retired President of Agricultural and Turf Division at Deere & Company, with extensive experience in agriculture and manufacturing. | |
Gregory R. Page Board | Non-Executive Chairman of the Board | Board Member at Eaton Corporation, Deere & Company, 3M, Alight, Big Brothers Big Sisters of America, Northern Star Council of the Boy Scouts of America | Non-Executive Chairman since June 2019, former CEO of Cargill, Inc., with extensive leadership experience in agriculture and food industries. | |
Janet P. Giesselman Board | Director | Director at McCain Foods Ltd., Twin Disc, Inc., Chair of the Board at Ag Growth International | Director since March 2021, former executive at Dow Chemical and Rohm and Haas, with expertise in agriculture, chemicals, and governance. | |
Karen H. Grimes Board | Director | Director at Toll Brothers, Inc., TEGNA, Inc. | Director since March 2021, former Senior Managing Director at Wellington Management, with expertise in finance, investment, and risk management. | |
Kerry J. Preete Board | Director | Director at Avient Corporation | Director since March 2021, former EVP and Chief Strategy Officer at Monsanto, with expertise in agriculture, chemicals, and business strategy. | |
Klaus A. Engel Board | Director | Supervisory Board Member at National-Bank, Advisory Board Member at Ruhr-University, Honorary Professor at University of Duisburg/Essen, Board of Trustees Member at Bonner Akademie | Director since June 2019, former CEO of Evonik Industries AG, with expertise in chemicals, R&D, and sustainability. | |
Lamberto Andreotti Board | Director | Deputy Chairman of UniCredit S.p.A. (retiring April 2024) | Director since June 2019, former CEO and Chairman of Bristol-Myers Squibb, with expertise in pharmaceuticals and global business leadership. | |
Marcos M. Lutz Board | Director | CEO of Ultrapar Participa\u00e7\u00f5es S.A., Board Member at Votorantim SA | Director since June 2019, former CEO of Cosan Limited, with expertise in logistics, energy, and agribusiness. | |
Michael O. Johanns Board | Director | Board Member at Deere & Company, Farm Foundation, Flinchbaugh Center for Ag Policy, Ag America Lending, Center for Infrastructure and Economic Development | Director since June 2019, former U.S. Secretary of Agriculture and U.S. Senator, with expertise in agriculture policy and governance. | |
Nayaki R. Nayyar Board | Director | CEO of Securonix, Inc., Director at TD SYNNEX Corporation | Director since February 2020, former EVP at SAP and Infosys, with expertise in IT, cybersecurity, and digital transformation. | |
Patrick J. Ward Board | Director | Director at Flex, Ltd. | Director since June 2019, former CFO of Cummins Inc., with expertise in finance, accounting, and capital markets. | |
Rebecca B. Liebert Board | Director | CEO of The Lubrizol Corporation, Director at TD SYNNEX Corporation | Director since June 2019, former EVP at PPG Industries and CEO of Honeywell UOP, with expertise in chemicals, engineering, and sustainability. |
- Given the 18% price decline in crop protection products in Brazil during the quarter, can you elaborate on the specific factors driving this deterioration and how you plan to navigate the ongoing competitive pressures in this key market?
- With organic sales down 5% and seed sales down 17% in the quarter, particularly a 25% decline in North American seed prices due to end-of-season settlements, what strategies are you implementing to reverse the downward trend in seed pricing and improve margins?
- Your initial outlook for 2025 suggests only moderate benefits from seed and crop protection cost deflation, despite industry expectations for larger deflationary impacts; can you explain why your estimates appear conservative and whether there is potential for greater upside?
- Considering the adjustment of your full-year operating EBITDA guidance to $3.4 billion at the midpoint due to unfavorable Latin American market conditions, what specific measures are you taking to mitigate these issues, and how confident are you in achieving this updated target?
- With the upcoming retirement of Tim Glenn and the transition to new leadership in your Seed business, how do you anticipate this change will impact your strategic execution in the Seed segment, especially given the current market challenges and the importance of innovation in driving growth?
Research analysts who have asked questions during Corteva earnings calls.
Christopher Parkinson
Wolfe Research
4 questions for CTVA
Edlain Rodriguez
Mizuho Securities
4 questions for CTVA
Joel Jackson
BMO Capital Markets
4 questions for CTVA
Kevin McCarthy
Vertical Research Partners
4 questions for CTVA
Vincent Andrews
Morgan Stanley
4 questions for CTVA
David Begleiter
Deutsche Bank
3 questions for CTVA
Frank Mitsch
Fermium Research
3 questions for CTVA
Joshua Spector
UBS
3 questions for CTVA
Patrick Cunningham
Citigroup
3 questions for CTVA
Aleksey Yefremov
KeyBanc Capital Markets
2 questions for CTVA
Arun Viswanathan
RBC Capital Markets
2 questions for CTVA
Jeffrey Zekauskas
JPMorgan Chase & Co.
2 questions for CTVA
Kristen Owen
Oppenheimer & Co. Inc.
2 questions for CTVA
Richard Garchitorena
Wells Fargo
2 questions for CTVA
Steve Byrne
Bank of America
2 questions for CTVA
Emily Fusco
Deutsche Bank
1 question for CTVA
Matthew Deyoe
Bank of America
1 question for CTVA
Patrick Fischer
Goldman Sachs
1 question for CTVA
Rachel Leon
Citigroup Inc.
1 question for CTVA
Salvo Latiano
Bank of America
1 question for CTVA
Notable M&A activity and strategic investments in the past 3 years.
| Company | Year | Details |
|---|---|---|
Stoller Group, Inc. | 2023 | Corteva acquired Stoller for $1,224 million (subject to a working capital adjustment) on March 1, 2023, to enhance its crop protection business with complementary biological tools. The deal included acquiring key assets such as cash, receivables, inventories, PP&E, and significant goodwill, with no material impact observed on the financial statements post-acquisition. |
Symborg | 2023 | Corteva completed the acquisition of Symborg for $370 million (subject to a working capital adjustment) on March 1, 2023, to expand its sustainable agricultural solutions and crop protection offerings. The deal involved acquiring assets including receivables, inventories, PP&E, and intangible assets like goodwill, thereby reinforcing its commitment to environmentally friendly technologies. |
Recent press releases and 8-K filings for CTVA.
- Corteva’s Board approved a tax-free spin-off into New Corteva (crop protection) and SpinCo (seed/genetics), targeting completion in 2026 to unlock long-term value.
- New Corteva reaffirms its 2025 full-year guidance and expects 2026 EBITDA of $4.1 billion at the midpoint.
- Since 2019, Corteva has delivered an 11% CAGR in operating EBITDA, 700 bps margin expansion, $7 billion returned to shareholders, and ~200% TSR, driven by innovation and cost discipline.
- Leadership roles: Greg Page will chair New Corteva; Chuck to become CEO of SpinCo; remaining executive appointments to follow.
- Corteva will spin into two independent companies—New Corteva (Crop Protection) and SpinCo (Seed)—in H2 2026; the transaction is intended to be tax-free, expects $80–100 M of dis-synergies, and both entities will target investment-grade ratings with legacy DuPont liabilities retained by New Corteva.
- New Corteva is projected to generate $7.8 B of revenue with ~17% Operating EBITDA margin in 2025E, while SpinCo is forecast at $9.9 B of revenue and ~26% margin for the same period.
- Since its 2019 separation, Corteva has delivered an 11% Operating EBITDA CAGR, improved margins by 700 bps, invested $8.9 B in R&D, returned $7 B to shareholders, and achieved ~200% total shareholder return through June 2025.
- New Corteva will focus on next-generation proprietary and biological solutions alongside supply-chain efficiency, whereas SpinCo will prioritize advanced genetics, gene editing, and expansion into biofuels and hybrid wheat markets.
- Corteva’s Board unanimously approved a plan to separate into two independent, publicly traded companies: New Corteva (crop protection) and SpinCo (seed business), with completion expected in H2 2026.
- Greg Page will chair New Corteva and Chuck Magro will become CEO of SpinCo after separation.
- Transaction structured as a tax-free spin-off for U.S. federal tax purposes, pending board approval, legal opinion, and SEC registration.
- 2025 net sales are estimated at $7.8 billion for New Corteva (44% of Corteva’s total) and $9.9 billion for SpinCo (56%).
- The companies will pay a total of $875 million over 25 years to resolve all state environmental and PFAS claims.
- Corteva’s share of the settlement’s net present value is 14.5% (≈$72 million).
- DuPont and Corteva will acquire Chemours’ PFAS-related insurance rights for $150 million, after which Chemours retains 50% of additional recoveries.
- The agreement creates a Remediation Funding Source and a surety-backed Reserve Fund capped at $475 million for site cleanup.
- Q1 performance: Corteva reported a 15% EBITDA increase year-over-year to $1.2 billion, driven by steady seed pricing, growth in crop protection products, and significant cost improvement actions, with first-quarter cost benefits of $200 million contributing to their guidance of $400 million for the year.
- Tariff impacts are being actively managed: despite a potential $50 million cost headwind, the company’s diversified supply chain (with only 2% of COGS from China and 70% of that multi-sourced) and planned cost reductions are expected to effectively mitigate these pressures.
- Strategic pipeline and integration progress: Corteva is advancing its long-term growth initiatives, including gene editing innovations, new product launches such as the Haviza fungicide for 2026 and a novel hybrid wheat targeting a 10-12% yield increase in 2027, as well as successful integration of acquisitions to enhance its biologicals portfolio.
- Full-year 2025 guidance reaffirmed: net sales of $17.2B–$17.6B, operating EBITDA of $3.6B–$3.8B, operating EPS of $2.70–$2.95, and a planned share repurchase of approximately $1B .
- Strong Q1 operating performance: Operating EBITDA increased by 15% to nearly $1.2B with an operating EBITDA margin expansion of almost 400 basis points .
- Q1 GAAP results: Net sales reached $4.42B (down 2% YoY), with organic sales growing by 3% and GAAP EPS at $0.97 .
- Segment highlights: The Seed segment delivered solid organic growth with a 13–15% increase in operating EBITDA, while the Crop Protection segment saw a 22% rise supported by volume gains and cost benefits .
- Cost and headwind management: Robust cost-saving initiatives are underway with progress toward a $400 million net cost target while managing currency and tariff headwinds, including a potential $50M tariff cost impact .